Skip to main content
Erschienen in: World Journal of Urology 4/2017

06.08.2016 | Original Article

Partial nephrectomy versus ablative therapy for the treatment of renal tumors in an imperative setting

verfasst von: Jean-Alexandre Long, Jean-Christophe Bernhard, Pierre Bigot, Cecilia Lanchon, Philippe Paparel, Nathalie Rioux-Leclercq, Laurence Albiges, Thomas Bodin, François-Xavier Nouhaud, Romain Boissier, Pierre Gimel, Arnaud Méjean, Alexandra Masson-Lecomte, Nicolas Grenier, Francois Cornelis, Yohann Grassano, Vincent Comat, Quentin Come Le Clerc, Jérome Rigaud, Laurent Salomon, Jean-Luc Descotes, Christian Sengel, Morgan Roupret, Gregory Verhoest, Idir Ouzaid, Valentin Arnoux, Karim Bensalah, for the French association of Urology Cancerology Comitee (CCAFU)

Erschienen in: World Journal of Urology | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To compare partial nephrectomy (PN) and percutaneous ablative therapy (AT) for renal tumor in imperative indication of nephron-sparing technique (NST).

Materials and methods

Between 2000 and 2015, 284 consecutive patients with a kidney tumor in an imperative indication of NST were retrospectively included in a multicenter study. PN [open (n = 146), laparoscopic (n = 9), or robotic approach (n = 17)] and AT [radiofrequency ablation (n = 104) or cryoablation (n = 8)] were performed for solitary kidney (n = 146), bilateral tumor (n = 78), or chronic kidney disease (CKD) (n = 60).

Results

Patients in the PN group had larger tumors and a higher RENAL score. There were no differences between the two groups with respect to age, reasons for imperative indication, and preoperative eGFR. Patients in the AT group had a higher ASA and CCI. PN had worse outcomes than AT in terms of transfusion rate, length of stay, and complication rate. Local radiological recurrence-free survival was better for PN, but metastatic recurrence was similar. Percentage of eGFR decrease was similar in the two groups. Temporary or permanent dialysis was not significantly different. On multivariate analysis, PN and AT had a similar eGFR change when adjusted for tumor complexity, reason of imperative indication and CCI.

Conclusion

In imperative indication of nephron-sparing treatment for a kidney tumor, either PN or AT can be proposed. PN offers the ability to manage larger and more complex tumors while providing a better local control and a similar renal function loss.
Literatur
1.
Zurück zum Zitat Long J-A, Lee B, Eyraud R et al (2012) Robotic partial nephrectomy: imperative vs elective indications. Urology 80:833–837CrossRefPubMed Long J-A, Lee B, Eyraud R et al (2012) Robotic partial nephrectomy: imperative vs elective indications. Urology 80:833–837CrossRefPubMed
2.
Zurück zum Zitat Ljungberg B, Bensalah K, Canfield S et al (2015) EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol 67:913–924CrossRefPubMed Ljungberg B, Bensalah K, Canfield S et al (2015) EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol 67:913–924CrossRefPubMed
3.
Zurück zum Zitat Guillotreau J, Haber G-P, Autorino R et al (2012) Robotic partial nephrectomy versus laparoscopic cryoablation for the small renal mass. Eur Urol 61:899–904CrossRefPubMed Guillotreau J, Haber G-P, Autorino R et al (2012) Robotic partial nephrectomy versus laparoscopic cryoablation for the small renal mass. Eur Urol 61:899–904CrossRefPubMed
4.
Zurück zum Zitat Psutka SP, Feldman AS, McDougal WS et al (2013) Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma. Eur Urol 63:486–492CrossRefPubMed Psutka SP, Feldman AS, McDougal WS et al (2013) Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma. Eur Urol 63:486–492CrossRefPubMed
5.
Zurück zum Zitat Dindo D, Demartines N, Clavien P-A (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213CrossRefPubMedPubMedCentral Dindo D, Demartines N, Clavien P-A (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Arnoux V, Descotes J-L, Sengel C et al (2013) Perioperative outcomes and mid-term results of radiofrequency ablation and partial nephrectomy in indications of renal tumor treatment and imperative nephron-sparing procedure. Prog En Urol J Assoc Fr Urol Société Fr Urol 23:99–104CrossRef Arnoux V, Descotes J-L, Sengel C et al (2013) Perioperative outcomes and mid-term results of radiofrequency ablation and partial nephrectomy in indications of renal tumor treatment and imperative nephron-sparing procedure. Prog En Urol J Assoc Fr Urol Société Fr Urol 23:99–104CrossRef
7.
Zurück zum Zitat Larcher A, Fossati N, Tian Z et al (2015) Prediction of complications following partial nephrectomy: implications for ablative techniques candidates. Eur Urol 69:676–682CrossRefPubMed Larcher A, Fossati N, Tian Z et al (2015) Prediction of complications following partial nephrectomy: implications for ablative techniques candidates. Eur Urol 69:676–682CrossRefPubMed
8.
Zurück zum Zitat Trudeau V, Becker A, Roghmann F et al (2014) Local tumor destruction in renal cell carcinoma—an inpatient population-based study. Urol Oncol 32(54):e1–e7 Trudeau V, Becker A, Roghmann F et al (2014) Local tumor destruction in renal cell carcinoma—an inpatient population-based study. Urol Oncol 32(54):e1–e7
9.
Zurück zum Zitat Guillotreau J, Yakoubi R, Long J-A et al (2012) Robotic partial nephrectomy for small renal masses in patients with pre-existing chronic kidney disease. Urology 80:845–851CrossRefPubMed Guillotreau J, Yakoubi R, Long J-A et al (2012) Robotic partial nephrectomy for small renal masses in patients with pre-existing chronic kidney disease. Urology 80:845–851CrossRefPubMed
10.
Zurück zum Zitat Long J-A, Yakoubi R, Lee B et al (2012) Robotic versus laparoscopic partial nephrectomy for complex tumors: comparison of perioperative outcomes. Eur Urol 61:1257–1262CrossRefPubMed Long J-A, Yakoubi R, Lee B et al (2012) Robotic versus laparoscopic partial nephrectomy for complex tumors: comparison of perioperative outcomes. Eur Urol 61:1257–1262CrossRefPubMed
11.
Zurück zum Zitat Lane BR, Novick AC, Babineau D et al (2008) Comparison of laparoscopic and open partial nephrectomy for tumor in a solitary kidney. J Urol 179:847–851 (discussion 852) CrossRefPubMed Lane BR, Novick AC, Babineau D et al (2008) Comparison of laparoscopic and open partial nephrectomy for tumor in a solitary kidney. J Urol 179:847–851 (discussion 852) CrossRefPubMed
12.
Zurück zum Zitat Panumatrassamee K, Kaouk JH, Autorino R et al (2013) Cryoablation versus minimally invasive partial nephrectomy for small renal masses in the solitary kidney: impact of approach on functional outcomes. J Urol 189:818–822CrossRefPubMed Panumatrassamee K, Kaouk JH, Autorino R et al (2013) Cryoablation versus minimally invasive partial nephrectomy for small renal masses in the solitary kidney: impact of approach on functional outcomes. J Urol 189:818–822CrossRefPubMed
13.
Zurück zum Zitat El Dib R, Touma NJ, Kapoor A (2012) Cryoablation vs. radiofrequency ablation for the treatment of renal cell carcinoma: a meta-analysis of case series studies. BJU Int 110:510–516CrossRefPubMed El Dib R, Touma NJ, Kapoor A (2012) Cryoablation vs. radiofrequency ablation for the treatment of renal cell carcinoma: a meta-analysis of case series studies. BJU Int 110:510–516CrossRefPubMed
15.
Zurück zum Zitat Tanagho YS, Bhayani SB, Kim EH et al (2013) Renal cryoablation versus robot-assisted partial nephrectomy: Washington University long-term experience. J Endourol Endourol Soc 27:1477–1486CrossRef Tanagho YS, Bhayani SB, Kim EH et al (2013) Renal cryoablation versus robot-assisted partial nephrectomy: Washington University long-term experience. J Endourol Endourol Soc 27:1477–1486CrossRef
16.
Zurück zum Zitat Thompson RH, Atwell T, Schmit G et al (2015) Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol 67:252–259CrossRefPubMed Thompson RH, Atwell T, Schmit G et al (2015) Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol 67:252–259CrossRefPubMed
Metadaten
Titel
Partial nephrectomy versus ablative therapy for the treatment of renal tumors in an imperative setting
verfasst von
Jean-Alexandre Long
Jean-Christophe Bernhard
Pierre Bigot
Cecilia Lanchon
Philippe Paparel
Nathalie Rioux-Leclercq
Laurence Albiges
Thomas Bodin
François-Xavier Nouhaud
Romain Boissier
Pierre Gimel
Arnaud Méjean
Alexandra Masson-Lecomte
Nicolas Grenier
Francois Cornelis
Yohann Grassano
Vincent Comat
Quentin Come Le Clerc
Jérome Rigaud
Laurent Salomon
Jean-Luc Descotes
Christian Sengel
Morgan Roupret
Gregory Verhoest
Idir Ouzaid
Valentin Arnoux
Karim Bensalah
for the French association of Urology Cancerology Comitee (CCAFU)
Publikationsdatum
06.08.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
World Journal of Urology / Ausgabe 4/2017
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI
https://doi.org/10.1007/s00345-016-1913-4

Weitere Artikel der Ausgabe 4/2017

World Journal of Urology 4/2017 Zur Ausgabe

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.